February 2011 Issue Table Of Contents

Editor’s Note

• And The Survey Says…

Ask The Board

• Ask The Board February 2011

Feature

• GSK’s Biopharm Plans
• Combining Good Science & Good Business
• Finding The Key To Biopharma Start-Up

Inside The Industry

• Making Decisions In The Pharma Cold Chain
• A Strategic Weapon To Protect Your IP
• Buttoning Down The Pharma Supply Chain
• How Biomarkers Can Pave The Critical Path For Drug Development
• An Assessment Of 5 Clinical Study Costing Methods
• Real-Time Patient Reporting Could Open The Door To FDA Inspection
• Economic Free Zones And Biopharma Development

Industry Leader

• Leveraging Drug Delivery Expertise To Drive New Product Opportunities
• Setting Realistic Aspirations